发明名称 |
Crystalline solid and amorphous forms of (−)- halofenate and methods related thereto |
摘要 |
The present invention provides crystalline solid and amorphous forms of (−)-halofenate. The crystalline solid forms may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of conditions associated with blood lipid deposition in a mammal, particularly those diseases related to Type 2 diabetes and hyperlipidemia. The invention also relates to a method for preventing or treating Type 2 diabetes and hyperlipidemia in a mammal comprising the step of administering a therapeutically effective amount of crystalline solid and amorphous forms of (−)-halofenate. |
申请公布号 |
US8203019(B2) |
申请公布日期 |
2012.06.19 |
申请号 |
US20060408609 |
申请日期 |
2006.04.20 |
申请人 |
METABOLEX, INC.;DIATEX, INC. |
发明人 |
DAUGS EDWARD D.;HAGEN ERIC J.;HANKO JASON A.;LOUKS DAVID H. |
分类号 |
C07C69/76;A61K31/22;A61K31/235;C07C67/02;C07C69/63 |
主分类号 |
C07C69/76 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|